• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

COVID-19 immunisation in older people.

作者信息

Vigezzi Giacomo Pietro, Odone Anna

机构信息

Department of Public Health, Experimental and Forensic Medicine, University of Pavia, Pavia, Italy.

Collegio Ca' della Paglia, Fondazione Ghislieri, Pavia, Italy.

出版信息

Lancet Healthy Longev. 2022 Mar;3(3):e126-e127. doi: 10.1016/S2666-7568(22)00036-8. Epub 2022 Feb 23.

DOI:10.1016/S2666-7568(22)00036-8
PMID:35224523
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8863501/
Abstract
摘要

相似文献

1
COVID-19 immunisation in older people.老年人的新冠病毒免疫接种
Lancet Healthy Longev. 2022 Mar;3(3):e126-e127. doi: 10.1016/S2666-7568(22)00036-8. Epub 2022 Feb 23.
2
Frail older people and those in deprived areas remain at risk from covid-19, even after vaccination.即使接种了疫苗，体弱的老年人和贫困地区的人仍然面临新冠病毒的风险。
BMJ. 2022 Jul 4;378:o1313. doi: 10.1136/bmj.o1313.
3
COVID-19 Vaccination for Frail Older Adults in Singapore - Rapid Evidence Summary and Delphi Consensus Statements.新加坡体弱老年人的 COVID-19 疫苗接种-快速证据摘要和德尔菲共识声明。
J Frailty Aging. 2022;11(2):236-241. doi: 10.14283/jfa.2022.12.
4
Immunogenicity after 6 months of BNT162b2 vaccination in frail or disabled nursing home residents: The COVID-A Study.接种 BNT162b2 疫苗 6 个月后在体弱或残疾的疗养院居民中的免疫原性：COVID-A 研究。
J Am Geriatr Soc. 2022 Mar;70(3):650-658. doi: 10.1111/jgs.17620. Epub 2021 Dec 17.
5
Frailty among Older People during the First Wave of the COVID-19 Pandemic in The Netherlands.荷兰新冠疫情第一波期间老年人的虚弱状况
Int J Environ Res Public Health. 2022 Mar 19;19(6):3669. doi: 10.3390/ijerph19063669.
6
Changes in psychological distress before and during the COVID-19 pandemic among older adults: the contribution of frailty transitions and multimorbidity.新冠疫情之前及期间老年人心理困扰的变化：虚弱转变和多种疾病的影响
Age Ageing. 2021 Jun 28;50(4):1011-1018. doi: 10.1093/ageing/afab061.
7
Decreased response to the mRNA anti-SARS-CoV-2 vaccine in hepatitis B vaccine non-responders and frail patients treated with peritoneal dialysis.乙型肝炎疫苗无应答者及接受腹膜透析治疗的体弱患者对mRNA抗SARS-CoV-2疫苗的反应降低。
Nephrol Dial Transplant. 2022 May 25;37(6):1188-1190. doi: 10.1093/ndt/gfac031.
8
Delirium triggered by COVID-19 vaccine in an elderly patient.一名老年患者中由新冠疫苗引发的谵妄
Geriatr Gerontol Int. 2021 Jun;21(6):540. doi: 10.1111/ggi.14163. Epub 2021 Apr 8.
9
Vaccination against seasonal influenza and socio-economic and environmental factors as determinants of the geographic variation of COVID-19 incidence and mortality in the Italian elderly.季节性流感疫苗接种和社会经济及环境因素是意大利老年人 COVID-19 发病率和死亡率地域差异的决定因素。
Prev Med. 2021 Feb;143:106351. doi: 10.1016/j.ypmed.2020.106351. Epub 2020 Dec 2.
10
Estimated Effectiveness of COVID-19 Messenger RNA Vaccination Against SARS-CoV-2 Infection Among Older Male Veterans Health Administration Enrollees, January to September 2021.2021 年 1 月至 9 月，老年男性退伍军人管理局参保者中 COVID-19 信使 RNA 疫苗对 SARS-CoV-2 感染的估计有效性。
JAMA Netw Open. 2021 Dec 1;4(12):e2138975. doi: 10.1001/jamanetworkopen.2021.38975.

引用本文的文献

1
Understanding the drivers and barriers of elderly vaccination in post-pandemic China: a qualitative study in Shenzhen.
BMC Public Health. 2025 Nov 28;25(1):4185. doi: 10.1186/s12889-025-25437-7.
2
Biomarkers of vaccine safety and efficacy in vulnerable populations: Lessons from the fourth international precision vaccines conference.弱势群体中疫苗安全性和有效性的生物标志物：第四届国际精准疫苗会议的经验教训
Vaccine. 2025 Jan 1;43(Pt 2):126477. doi: 10.1016/j.vaccine.2024.126477. Epub 2024 Nov 28.
3
Vaccine Mandates in the COVID-19 Era: Changing Paradigm or Public Health Opportunity? Comment on "Convergence on Coercion: Functional and Political Pressures as Drivers of Global Childhood Vaccine Mandates".新冠疫情时代的疫苗强制接种令：改变范式还是公共卫生契机？评“趋同于强制：全球儿童疫苗强制接种令的功能与政治压力驱动因素”。

本文引用的文献

1
Real-world serological responses to extended-interval and heterologous COVID-19 mRNA vaccination in frail, older people (UNCoVER): an interim report from a prospective observational cohort study.真实世界中衰弱老年人接受延长间隔和异源 COVID-19 mRNA 疫苗接种后的血清学反应（UNCoVER）：一项前瞻性观察队列研究的中期报告。
Lancet Healthy Longev. 2022 Mar;3(3):e166-e175. doi: 10.1016/S2666-7568(22)00012-5. Epub 2022 Feb 23.
2
Homologous and Heterologous Covid-19 Booster Vaccinations.同源和异源 COVID-19 加强针接种。
N Engl J Med. 2022 Mar 17;386(11):1046-1057. doi: 10.1056/NEJMoa2116414. Epub 2022 Jan 26.
3
Int J Health Policy Manag. 2023;12:7616. doi: 10.34172/ijhpm.2022.7616. Epub 2022 Dec 28.
Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre, randomised, controlled, phase 2 trial.
在英国，用 ChAdOx1 nCov-19 或 BNT162b2 接种两剂后作为第三剂（加强针）接种 7 种 COVID-19 疫苗的安全性和免疫原性（COV-BOOST）：一项盲法、多中心、随机、对照、2 期试验。
Lancet. 2021 Dec 18;398(10318):2258-2276. doi: 10.1016/S0140-6736(21)02717-3. Epub 2021 Dec 2.
4
Safety surveillance after BNT162b2 mRNA COVID-19 vaccination: results from a cross-sectional survey among staff of a large Italian teaching hospital.BNT162b2 mRNA COVID-19 疫苗接种后的安全性监测：一项大型意大利教学医院工作人员横断面调查的结果。
Acta Biomed. 2021 Oct 1;92(S6):e2021450. doi: 10.23750/abm.v92iS6.12217.
5
The Use of Digital Technologies to Support Vaccination Programmes in Europe: State of the Art and Best Practices from Experts' Interviews.利用数字技术支持欧洲的疫苗接种计划：专家访谈的最新情况与最佳实践
Vaccines (Basel). 2021 Oct 3;9(10):1126. doi: 10.3390/vaccines9101126.
6
COVID-19 lockdown impact on lifestyle habits of Italian adults.新冠疫情封锁对意大利成年人生活习惯的影响。
Acta Biomed. 2020 Jul 20;91(9-S):87-89. doi: 10.23750/abm.v91i9-S.10122.
7
The COVID-19 pandemic and health inequalities.新型冠状病毒肺炎大流行与卫生不平等。
J Epidemiol Community Health. 2020 Nov;74(11):964-968. doi: 10.1136/jech-2020-214401. Epub 2020 Jun 13.
8
Life-course immunization as a gateway to health.人生全程免疫接种作为通向健康的途径。
Expert Rev Vaccines. 2018 Oct;17(10):851-864. doi: 10.1080/14760584.2018.1527690.